Skip to Content

News List

Dr. Bucshon Hails Passage of Five Year Farm Bill Reauthorization

| Posted in Press Releases

(Washington, D.C.) – Congressman Larry Bucshon, M.D. (IN-08) released the following statement after the House passed the Agriculture Improvement Act (H.R. 2), a five year authorization of the Farm Bill: “Hoosier family farmers employ thousands across the state and are vitally important to Indiana’s economic output – ranking among…

Dr. Bucshon Supports Trump Administration’s New Waters of the United States Rule

| Posted in Press Releases

(Washington, D.C.) – Congressman Larry Bucshon, M.D. (IN-08) released the following statement in support of the Trump Administration’s new Waters of the United States (WOTUS) rule: “Under the Obama Administration, the Environmental Protection Agency attempted to expand the federal government’s jurisdiction to control practically any…

Rep. Bucshon supports Trump administration's new Waters of the United States rule

| Posted in In the News

Rep. Larry Bucshon said on Tuesday that he supports the administration’s new Waters of the United States rule. Rep. Bucshon released this statement: “Under the Obama Administration, the Environmental Protection Agency attempted to expand the federal government’s jurisdiction to control practically any body of water, whether it be…

Capitol Hill Healthcare Update

| Posted in In the News

A bipartisan group of lawmakers last week distributed draft legislation that would give the FDA authority to regulate laboratory-developed tests. The draft was released by Reps. Larry Bucshon, R-Ind., and Diana DeGette, D-Colo., retiring Senate Finance Committee Chairman Orrin Hatch, R-Utah, and Sen. Michael Bennet, D-Colo. Current law…

FDA guide unveils vision for cancer diagnostics

| Posted in In the News

Dive Brief: FDA Thursday released new draft guidance outlining the agency's thinking on considerations for developing and labeling in vitro companion diagnostic devices for specific classes of oncology therapeutic products. The effort comes as the agency approves more targeted medicines for specific disease subtypes. But while targeted…